Bernhard Banas is an expert in Surgery at University Hospital Regensburg (Germany). As of October 2026, ScienceLeadR ranks Bernhard Banas in the top 1% of experts worldwide for Kidney Transplantation. Bernhard Banas has authored 270 publications, the most recent in 2026, and is an investigator in 15 clinical trials, 2 of them ongoing. SLR score: 796 (community average: 125). How the SLR is computed.

LeadR Profile

Bernhard Banas University Hospital Regensburg Germany
796 ScienceLeadR Reputation 796
Network Map

Surgery

Subspecialties: Transplantation - Nephrology - Endocrinology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1996 - 2026

Source: PubMed

University Hospital Regensburg

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 270

Citations

Citations: 11 495 1st author: 23 Last author: 40 Unique author: 0


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
A multicenter registry study of the CD38 antibody daratumumab for the treatment of microvascular inflammation following kidney transplantation.
PMID 42492852 — registries, kidney diseases, albuminuria, kidney, diagnosis, transplants, therapeutics, kidney transplantation, transplantation
Kidney Int20262
Anti-BAFF treatment modulates intragraft fibrosis and DKK3 expression in a non-adherence model of experimental kidney transplantation.
PMID 41997377 — cells, fibrosis, kidney, cyclosporine, transplants, therapeutics, kidney transplantation, immunosuppression therapy, transplantation
Transpl Immunol20260
Diagnosis of early kidney allograft rejection: influencing factors in metabolite-based urine analysis.
PMID 41868242 — kidney, biopsy, metabolomics, diagnosis, transplants, therapeutics, kidney transplantation, ischemia, allografts, transplantation
Front Med (Lausanne)20260
A Prospective Multicenter Luminex-Based Clinical Algorithm to Define Unacceptable HLA Mismatches Before Kidney Transplantation. Consequences on Outcome, Waiting Time, and Wait List Composition.
PMID 41641022 — waiting lists, antibodies, kidney, algorithms, transplants, kidney transplantation, transplantation
Transpl Int20260
Acute Rejection With DSA-Negative Severe Microvascular Inflammation in a Kidney Transplant Recipient With an Isolated DPB1*04-Mismatch Successfully Stabilised With Daratumumab.
PMID 41514512 — cells, absenteeism, kidney, hla antigens, transplants, allografts
HLA20260

Clinical Studies 15

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 3

By phase:

Phase 4 7
N/A 3
Phase 1/Phase 2 2
Phase 3 2
Phase 2 1

By status:

Completed 11
Active not recruiting 1
Recruiting 1
Terminated 1
Unknown 1

By type:

Interventional 12
Observational 3

By Monocentric/Multicentric:

monocentric 5
multicentric2to4 0
multicentric5to9 1
multicentricup10 9

Main Topics

Cohort/Consortium Investigators 2

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Multicentre open label randomised two arm parallel group superiority trial to assess bioavailability and practicability of two once daily tacrolimus formulations Envarsus compared with Advagraf administered in kidney transplant recipients
2023-503531-18-00 — graft rejection, biological availability, kidney, tacrolimus, transplants, allografts
Phase 4Active not recruiting2024
Tacrolimus C D Ratio Measured in Renal Transplant Recipients Treated With Once daily Prolonged release Drugs
NCT06268769 — biological availability, blood, pharmaceutical preparations, tablets, kidney, tacrolimus, capsules, transplants, therapeutics, kidney transplantation, immunosuppression therapy, transplantation
Phase 4Recruiting2024

LeadR Networks

Main global connection map